Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 4q1c.1

Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 8 {2,2'-[{4-[(2R)-4-{[(4,6-diaminopyrimidin-2-yl)sulfanyl]methyl}-5-propyl-2,3-dihydro-1,3-thiazol-2-yl]benzene-1,2-diyl}bis(oxy)]diethanol}

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.00 Å
Oligo State
homo-dimer
Ligands
2 x 2XM: 2,2'-((4-(4-(((4,6-diaminopyrimidin-2-yl)thio)methyl)-5-propylthiazol-2-yl)-1,2-phenylene)bis(oxy))bis(ethan-1-ol)(Non-covalent)
2 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Nomme, J. et al., Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability. J.Med.Chem. (2014)
Release Date
2014-11-05
Peptides
Deoxycytidine kinase: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Deoxycytidine kinase

Related Entries With Identical Sequence

4jlj.1 | 4jlk.1 | 4jlm.1 | 4jln.1 | 4kcg.1 | 4l5b.1 | 4q18.1 | 4q19.1 | 4q1a.1 | 4q1b.1 | 4q1d.1 | 4q1e.1 | 4q1f.1 | 7zi1.1 | 7zi2.1 | 7zi3.1 | 7zi5.1 | 7zi6.1 | 7zi7.1 | 7zi8.1 | 7zi9.1 | 7zia.1 | 7zib.1 | 8ooj.1 | 8ooj.2 | 8ooj.3